These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18346269)

  • 1. Hypermethylated MAL gene - a silent marker of early colon tumorigenesis.
    Lind GE; Ahlquist T; Kolberg M; Berg M; Eknaes M; Alonso MA; Kallioniemi A; Meling GI; Skotheim RI; Rognum TO; Thiis-Evensen E; Lothe RA
    J Transl Med; 2008 Mar; 6():13. PubMed ID: 18346269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MAL promoter hypermethylation as a novel prognostic marker in gastric cancer.
    Buffart TE; Overmeer RM; Steenbergen RD; Tijssen M; van Grieken NC; Snijders PJ; Grabsch HI; van de Velde CJ; Carvalho B; Meijer GA
    Br J Cancer; 2008 Dec; 99(11):1802-7. PubMed ID: 19002170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated MAL expression is accompanied by promoter hypomethylation and platinum resistance in epithelial ovarian cancer.
    Lee PS; Teaberry VS; Bland AE; Huang Z; Whitaker RS; Baba T; Fujii S; Secord AA; Berchuck A; Murphy SK
    Int J Cancer; 2010 Mar; 126(6):1378-89. PubMed ID: 19642140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic silencing of MAL, a putative tumor suppressor gene, can contribute to human epithelium cell carcinoma.
    Cao W; Zhang ZY; Xu Q; Sun Q; Yan M; Zhang J; Zhang P; Han ZG; Chen WT
    Mol Cancer; 2010 Nov; 9():296. PubMed ID: 21092172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-lymphocyte maturation-associated protein gene as a candidate metastasis suppressor for head and neck squamous cell carcinomas.
    Beder LB; Gunduz M; Hotomi M; Fujihara K; Shimada J; Tamura S; Gunduz E; Fukushima K; Yaykasli K; Grenman R; Shimizu K; Yamanaka N
    Cancer Sci; 2009 May; 100(5):873-80. PubMed ID: 19445022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA hypermethylation of MAL: a promising diagnostic biomarker for colorectal tumors.
    Lind GE; Ahlquist T; Lothe RA
    Gastroenterology; 2007 Apr; 132(4):1631-2; author reply 1632. PubMed ID: 17408629
    [No Abstract]   [Full Text] [Related]  

  • 7. DNA hypermethylation and decreased mRNA expression of MAL, PRIMA1, PTGDR and SFRP1 in colorectal adenoma and cancer.
    Kalmár A; Péterfia B; Hollósi P; Galamb O; Spisák S; Wichmann B; Bodor A; Tóth K; Patai ÁV; Valcz G; Nagy ZB; Kubák V; Tulassay Z; Kovalszky I; Molnár B
    BMC Cancer; 2015 Oct; 15():736. PubMed ID: 26482433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of the MAL gene in breast cancer is a common event that predicts benefit from adjuvant chemotherapy.
    Horne HN; Lee PS; Murphy SK; Alonso MA; Olson JA; Marks JR
    Mol Cancer Res; 2009 Feb; 7(2):199-209. PubMed ID: 19208741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene methylation profiles of normal mucosa, and benign and malignant colorectal tumors identify early onset markers.
    Ahlquist T; Lind GE; Costa VL; Meling GI; Vatn M; Hoff GS; Rognum TO; Skotheim RI; Thiis-Evensen E; Lothe RA
    Mol Cancer; 2008 Dec; 7():94. PubMed ID: 19117505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repression of MAL tumour suppressor activity by promoter methylation during cervical carcinogenesis.
    Overmeer RM; Henken FE; Bierkens M; Wilting SM; Timmerman I; Meijer CJ; Snijders PJ; Steenbergen RD
    J Pathol; 2009 Nov; 219(3):327-36. PubMed ID: 19662663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypermethylation and decreased expression of TMEM240 are potential early-onset biomarkers for colorectal cancer detection, poor prognosis, and early recurrence prediction.
    Chang SC; Liew PL; Ansar M; Lin SY; Wang SC; Hung CS; Chen JY; Jain S; Lin RK
    Clin Epigenetics; 2020 May; 12(1):67. PubMed ID: 32398064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADAMTS1, CRABP1, and NR3C1 identified as epigenetically deregulated genes in colorectal tumorigenesis.
    Lind GE; Kleivi K; Meling GI; Teixeira MR; Thiis-Evensen E; Rognum TO; Lothe RA
    Cell Oncol; 2006; 28(5-6):259-72. PubMed ID: 17167179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic unmasking of epigenetically silenced genes in breast cancer.
    Ostrow KL; Park HL; Hoque MO; Kim MS; Liu J; Argani P; Westra W; Van Criekinge W; Sidransky D
    Clin Cancer Res; 2009 Feb; 15(4):1184-91. PubMed ID: 19228724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer.
    Gu S; Lin S; Ye D; Qian S; Jiang D; Zhang X; Li Q; Yang J; Ying X; Li Z; Tang M; Wang J; Jin M; Chen K
    Clin Epigenetics; 2019 Mar; 11(1):41. PubMed ID: 30846004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gene methylation in stool for the screening of colorectal cancer and pre-malignant lesions].
    Kang YP; Cao FA; Chang WJ; Lou Z; Wang H; Wu LL; Fu CG; Cao GW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Jan; 14(1):52-6. PubMed ID: 21271382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant methylation of the CDH13 (H-cadherin) promoter region in colorectal cancers and adenomas.
    Toyooka S; Toyooka KO; Harada K; Miyajima K; Makarla P; Sathyanarayana UG; Yin J; Sato F; Shivapurkar N; Meltzer SJ; Gazdar AF
    Cancer Res; 2002 Jun; 62(12):3382-6. PubMed ID: 12067979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of PCR-based biomarker assay methods for colorectal polyp detection from fecal DNA.
    Ausch C; Kim YH; Tsuchiya KD; Dzieciatkowski S; Washington MK; Paraskeva C; Radich J; Grady WM
    Clin Chem; 2009 Aug; 55(8):1559-63. PubMed ID: 19541867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disentangling tumorigenesis-associated DNA methylation changes in colorectal tissues from those associated with ageing.
    Orjuela S; Parker HR; Sajibu S; Cereatti F; Sauter M; Buffoli F; Robinson MD; Marra G
    Epigenetics; 2022 Jun; 17(6):677-694. PubMed ID: 34369258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypermethylation of CpG island in O6-methylguanine-DNA methyltransferase gene was associated with K-ras G to A mutation in colorectal tumor.
    Qi J; Zhu YQ; Huang MF; Yang D
    World J Gastroenterol; 2005 Apr; 11(13):2022-5. PubMed ID: 15800999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ROR2 is epigenetically inactivated in the early stages of colorectal neoplasia and is associated with proliferation and migration.
    Ma SS; Srivastava S; Llamosas E; Hawkins NJ; Hesson LB; Ward RL; Ford CE
    BMC Cancer; 2016 Jul; 16():508. PubMed ID: 27440078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.